Experimental therapies to support the failing lung

AACN Clinical Issues
T S AhrensT Nienhaus

Abstract

Many conventional therapies are designed to treat acute lung injury. Although evidence exists that improved outcomes are a result of these therapies, mortality remains high in this population. Perhaps one of the key reasons why mortality remains high in the failing lung population is that current therapies do not "cure" the problem; current therapies are designed to support the lung, rather than fix the pulmonary problem. In this paper, a review of new and experimental therapies to support the failing lung are presented. Therapies such as prone positioning, nitric oxide, and mediator therapies are addressed. It is likely that newer therapies offer the most hope for improving the high mortality associated with acute lung injury.

References

Jan 1, 1976·Critical Care Medicine·M A Piehl, R S Brown
Feb 1, 1992·Journal of Applied Physiology·W K AdkinsA E Taylor
Sep 30, 1991·The American Journal of Medicine·G R Bernard
Dec 1, 1988·The American Review of Respiratory Disease·M J Tobin
Jan 1, 1988·The American Review of Respiratory Disease·P SestiniA Tagliabue
Jul 1, 1988·Chest·M LangerL Gattinoni
Jul 1, 1995·American Journal of Respiratory and Critical Care Medicine·P C RidingsA A Fowler
Apr 1, 1995·American Journal of Respiratory and Critical Care Medicine·G I SnellT J Williams
Apr 24, 1995·Archives of Internal Medicine·G A GourleyT H Self
Jan 25, 1995·JAMA : the Journal of the American Medical Association·J A MilbergL D Hudson
Jan 1, 1995·Southern Medical Journal·G P Giacoia
Mar 1, 1995·Mayo Clinic Proceedings·R J Lunn
Jan 1, 1994·Advances in Pharmacology·W M Zapol, W E Hurford
Jan 1, 1995·Irish Journal of Medical Science·S C Donnelly
Oct 1, 1994·British Journal of Anaesthesia·J D YoungS R Finfer
Jul 1, 1994·American Journal of Respiratory and Critical Care Medicine·W J LammR K Albert
Feb 1, 1993·AACN Clinical Issues in Critical Care Nursing·T Ahrens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Clinical Pathology
C O Burdick
Rhode Island Medical Journal
W Bennett
The American Journal of Nursing
R Davis
© 2021 Meta ULC. All rights reserved